Omnicell IncOMCL
Price$33.44Intrinsic value$46.2338% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $46.23median of 6 methods · middle span $28-$83based on filings through 30 Jun 2026
Market Price $33.44Price as of 1 Oct 2026
Margin of Safety +38.3%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 4.3% (near-term consensus, capped) · years 2–5: 17.8%/yr (balance of the path).14.9% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 614.8%Yr 711.9%Yr 88.9%Yr 96.0%Yr 103.0%
17.8% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 3 windows (5/6/7y)-44.2%
Discount rate (cost of equity) 9.3%
Volatility vs market (adjusted beta)0.97

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetOmnicell IncOMCLHealth Care
Valuation
P/E39.8×
P/S1.2×
P/B1.2×
EV / Revenue1.1×
EV / EBITDA14.5×
Profitability
Gross margin43.6%
Operating margin5.5%
Net margin3.1%
FCF margin11.4%
Returns
ROE3.0%
ROA2.0%
ROIC3.3%
Growth
Revenue growth (YoY)12.1%
5-yr fwd EPS growth14.9%
Financial strength
Debt / Equity0.13×
Current ratio1.64×
Altman Z-Score2.5
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.